期刊文献+

心力衰竭患者血浆N终端脑钠肽与心功能关系的研究 被引量:23

Study on the Relationship Between NT-proBNP and Cardiac Function
在线阅读 下载PDF
导出
摘要 目的:探讨心力衰竭患者血浆N终端脑钠肽(NT-proBNP)浓度对心功能的评价作用。方法:选择我院门诊及住院心力衰竭患者84例,正常对照组30例。用酶联免疫吸附测定法(ELISA)检测受试者血浆NT-proBNP浓度,超声心动图测定不同心功能组患者左心室射血分数(LVEF)及二尖瓣舒张早期流速峰/二尖瓣舒张晚期流速峰值(E/A)。所得结果进行统计检验,分析心力衰竭患者血浆NT-proBNP浓度与心力衰竭严重程度及LVEF、E/A的相关性,同时比较不同类型左心室功能障碍患者的NT-proBNP浓度。结果:心力衰竭患者血浆NT-proBNP浓度较对照组显著增高,且随着心力衰竭程度的加重而明显增加(P<0.01)。方差分析显示不同类型左心室功能障碍各组间NT-proBNP浓度存在差异性(P<0.05)。相关分析显示,NT-proBNP浓度与INEF、E/A存在显著负相关(r=-0.773,P<0.01;r=-0.659,P<0.01)。结论:NT-proBNP可以客观准确评价心功能,可作为一项临床诊断心力衰竭的实验室指标。 Objective:To determine the effects of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP), on cardic function in patients with heart failure. Methods:One hundred and fourteen subjects were selected, including 30 healthy controls and 84 patients with heart failure. The plasma NT-proBNP was determined by enzyme-labeled immunosorbent assay (ELISA). Left ventricular ejection fraction ( LVEF), mitral annular early diastolic (E) and late diastolic (A) inflow velocities were measured by modified Simpson's equation with echocardiography. Results:The plasma NT-proBNP concentrations of heart failure patients were significantly higher than those of the normal controls. They also increased with the increased severity of heart failure(P 〈 0. 01 ). NT-proBNP plasma levels were different between types of heart failure( P 〈0.05 ). The plasma level of NT-proBNP had significant negative correlation with LVEF and E/A (r= -0.773,P〈0.01; r= -0.659, P〈0.01). Conclusion : Plasma NT-proBNP is a useful index for the evalution of cardiac function.
出处 《中国循环杂志》 CSCD 北大核心 2006年第3期172-174,共3页 Chinese Circulation Journal
关键词 利钠肽 心力衰竭 心室功能障碍 Natriuretic peptide, brain Heart failure Ventricular dysfunction
  • 相关文献

参考文献12

  • 1Wijbenga JA, Balk AH, Boomsma F, et al. Cardiac peptides differ in their response to exercise:Implications for patients with heart failure in clinical practice. Eur Heart J, 1999,20(19) :1424-1428.
  • 2Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care : a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail, 2004,6: 295-300.
  • 3Kirk V, Bay M, Parner J, et al. N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Failure Study (CHHF). Eur J Heart Fail, 2004,6: 335-341.
  • 4Maisel A. B-type natriuretic peptide levels: A petiatial novel " white count" for congestive heart failure. J Cardic Failure, 2001,7(2) : 183.
  • 5McCullough PA, Omland T, Maisel AS. B-type natriuretic peptides:a diagnosis breakthrough for clinicians. Rev Cardiovac Med, 2003,4 ( 2 ) :72-82.
  • 6李永健,王林,陈元禄,陈康寅,周丽娟.N-末端脑钠素原对冠心病心力衰竭诊断及预后判断的价值[J].天津医药,2004,32(6):333-335. 被引量:7
  • 7Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int,2003,45:249-254.
  • 8黄陈军,朱文玲,陈连凤,郭丽琳,林雪.N-末端心房利钠肽和脑利钠肽对充血性心力衰竭的诊断意义[J].中华心血管病杂志,2003,31(6):405-407. 被引量:41
  • 9高伟,王士雯,赵玉生.脑钠肽前体N末端片段在心血管病研究应用中的现状[J].中华心血管病杂志,2004,32(8):759-761. 被引量:65
  • 10曾高峰,祁述善,周胜华.N端脑钠尿肽激素原血浆浓度与慢性心衰严重程度的关系[J].中国医师杂志,2003,5(7):881-882. 被引量:9

二级参考文献35

  • 1Edwards BS, Zimmermann RS, Burnett JC Jr. Atrial natriuretic factor: physiologic action and implications in congestive heart failure.Cardiovasc Drugs Ther,1987, 1 : 89-100.
  • 2Hunt PJ, Yandle TG, Nicholls MG, et al. The amino-terminal portion of pro-brain natriuretic peptide (pro-BNP) circulates in human plasma. Biochem Biophysl Res Commun, 1995, 214:1175-1183.
  • 3Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive aminoterminal pro-brain natriuretie peptide (NT-PROBNP) : a new marker of cardiac impairment. Clin Endocrinol, 1997, 47 : 287-296.
  • 4Sahn D J, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation of M-mode echecardiography: results of survey of echecardiography measurements. Circulation, 1978, 58 : 1072-1083.
  • 5Vogeser M, Jacob K. B-type natriuretic peptide (BNP)--validation of an immediate response assay. Clin Lab, 2001, 47:29-33.
  • 6Sayama H, Nakamura Y, Saito N, et al. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron Artery Dis. 1999. 10:537-540.
  • 7Maeda K, Tsutamoto T, Wada A, et al. Plasma Brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure with symptomatic left ventricular dysfunction. Am. Heart J,1998, 135:825-832.
  • 8Hall C, Kjekshus J, Eneroch P, et al. The plasma concentration of N-terminal proatrial natriuretie factor ANF (1-98) is related to prognosis in severe heart failure. Clin Cardiol, 1994, 17:191-195.
  • 9Masson S, Vago T, Baldi G, et al. Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin Chem Lab Med, 2002, 40(8) :761 -763.
  • 10Groenning BA, Nilsson JC, Sondergaard L, et al. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J,2002, 143 (5) : 923 - 929.

共引文献136

同被引文献143

引证文献23

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部